The drug hub of Bombay , India , has emerged as a crucial center for the creation of Tetrabenazine API (CAS No. 58-46-8). Several established companies are specializing in the creation of this critical active pharmaceutical ingredient. These firms often offer Tetrabenazine to both the local and international markets, adhering to stringent regulator